BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.

Clinical trial NCT07605429 · RECRUITING

Trial details

NCT number: NCT07605429
Sponsor: OHB Pediatrics Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Angelman Syndrome

Start date: 2026-06-01
Primary completion: 2029-03-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.